Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Honda, H.
Kato, H.
Olsen, M.A.
Reske, K.A.
Senoh, M.
Fukuda, T.
Tagashira, Y.
Mahe, C.
Dubberke, E.R.
Horiuchi, H.
Chiba, H.
Suzuki, D.
Hosokawa, N.
Kitazono, H.
Norisue, Y.
Kume, H.
Mori, N.
Morikawa, H.
Kashiwagura, S.
Higuchi, A.
Kato, H.
Nakamura, M.
Ishiguro, S.
Morita, S.
Ishikawa, H.
Watanabe, T.
Kojima, K.
Yokomaku, I.
Bando, T.
Toimoto, K.
Moriya, K.
Kasahara, K.
Kitada, S.
Ogawa, J.
Saito, H.
Tominaga, H.
Shimizu, Y.
Masumoto, F.
Tadera, K.
Yoshida, J.
Kikuchi, T.
Yoshikawa, I.
Watanabe, T.
Honda, M.
Yokote, K.
Toyokawa, T.
Miyazato, H.
and
Nakama, M.
2020.
Risk factors for Clostridioides difficile infection in hospitalized patients and associated mortality in Japan: a multi-centre prospective cohort study.
Journal of Hospital Infection,
Vol. 104,
Issue. 3,
p.
350.
Olmedo, María
Valerio, Maricela
Reigadas, Elena
Marín, Mercedes
Alcalá, Luis
Muñoz, Patricia
and
Bouza, Emilio
2020.
Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention.
JAC-Antimicrobial Resistance,
Vol. 2,
Issue. 3,
Robertson, C.
Pan, J.
Kavanagh, K.
Ford, I.
McCowan, C.
Bennie, M.
Marwick, C.
and
Leanord, A.
2020.
Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland.
Journal of Hospital Infection,
Vol. 106,
Issue. 3,
p.
554.
Rauseo, Adriana M
Olsen, Margaret A
Reske, Kimberly A
and
Dubberke, Erik R
2020.
Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly.
Expert Review of Anti-infective Therapy,
Vol. 18,
Issue. 3,
p.
203.
Olmedo, María
Alcalá, Luis
Valerio, Maricela
Marín, Mercedes
Onori, Raffaella
Reigadas, Elena
Muñoz, Patricia
and
Bouza, Emilio
2020.
Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior.
Diagnostic Microbiology and Infectious Disease,
Vol. 97,
Issue. 3,
p.
115050.
Enoch, D.A.
Murray-Thomas, T.
Adomakoh, N.
Dedman, D.
Georgopali, A.
Francis, N.A.
and
Karas, A.
2020.
Risk of complications and mortality following recurrent and non-recurrent Clostridioides difficile infection: a retrospective observational database study in England.
Journal of Hospital Infection,
Vol. 106,
Issue. 4,
p.
793.
Rajasingham, Radha
Enns, Eva A
Khoruts, Alexander
and
Vaughn, Byron P
2020.
Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines.
Clinical Infectious Diseases,
Vol. 70,
Issue. 5,
p.
754.
Shah, Niyati H
Shutt, Kathleen A
and
Doi, Yohei
2021.
Ampicillin-Ceftriaxone vs Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score–Matched, Retrospective Cohort Analysis.
Open Forum Infectious Diseases,
Vol. 8,
Issue. 4,
Makar, Michael
Makar, Gabriel
Xia, Weiyi
Greenberg, Patricia
and
Patel, Anish Vinit
2021.
Association of Clostridioides difficile with adverse clinical outcomes in patients with acute diverticulitis: A nationwide study.
Journal of Gastroenterology and Hepatology,
Vol. 36,
Issue. 4,
p.
983.
Kumar, Aneesh
Ghazanfar, Haider
and
Davidson, Joshua M
2021.
A Rare Case of Arterial and Venous Thromboembolism in a Patient With Severe Clostridium difficile Infection.
Cureus,
Hung, Yuan-Pin
Lee, Jen-Chieh
Tsai, Bo-Yang
Wu, Jia-Ling
Liu, Hsiao-Chieh
Liu, Hsiu-Chuan
Lin, Hsiao-Ju
Tsai, Pei-Jane
and
Ko, Wen-Chien
2021.
Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration.
Journal of Microbiology, Immunology and Infection,
Vol. 54,
Issue. 2,
p.
276.
Shen, Ye
Ellison, Jennifer
Leal, Jenine
Bush, Kathryn R.
Chandran, A. Uma
Fathima, Sumana
and
Conly, John M.
2021.
The use of laboratory-identified event surveillance to classify adverse outcomes due toClostridioides difficileinfection in Canadian long-term care facilities.
Infection Control & Hospital Epidemiology,
Vol. 42,
Issue. 5,
p.
557.
van der Kooi, Tjallie
Lepape, Alain
Astagneau, Pascal
Suetens, Carl
Nicolaie, Mioara Alina
de Greeff, Sabine
Lozoraitiene, Ilma
Czepiel, Jacek
Patyi, Márta
and
Plachouras, Diamantis
2021.
Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018.
Eurosurveillance,
Vol. 26,
Issue. 23,
Ooijevaar, R. E.
van Nood, E.
Goorhuis, A.
Terveer, E. M.
van Prehn, J.
Verspaget, H. W.
van Beurden, Y. H.
Dijkgraaf, M. G. W.
and
Keller, J. J.
2021.
Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature.
Microorganisms,
Vol. 9,
Issue. 3,
p.
548.
Tortajada-Girbés, Miguel
Rivas, Alejandro
Hernández, Manuel
González, Ana
Ferrús, Maria A.
and
Pina-Pérez, Maria C.
2021.
Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection.
Foods,
Vol. 10,
Issue. 5,
p.
1124.
Sutton, S. Scott
Magagnoli, Joseph
Cummings, Tammy H.
and
Hardin, James W.
2022.
Melatonin as an Antimicrobial Adjuvant and Anti-Inflammatory for the Management of Recurrent Clostridioides difficile Infection.
Antibiotics,
Vol. 11,
Issue. 11,
p.
1472.
Aby, Elizabeth S
Vaughn, Byron P
Enns, Eva A
and
Rajasingham, Radha
2022.
Cost-effectiveness of Fecal Microbiota Transplantation for First RecurrentClostridioides difficileInfection.
Clinical Infectious Diseases,
Vol. 75,
Issue. 9,
p.
1602.
Hirsch, Bruce E.
Williams, Myia S.
Stefanov, Dimitre G.
Lesser, Martin L.
Pappas, Karalyn
Iglio, Thomas
Gordon, Craig
and
Pekmezaris, Renee
2022.
Health care consequences of hospitalization with Clostrioides difficile infection: a propensity score matching study.
BMC Infectious Diseases,
Vol. 22,
Issue. 1,
Lin, Cheng-Yu
Cheng, Hao-Tsai
Kuo, Chia-Jung
Lee, Yun-Shien
Sung, Chang-Mu
Keidan, Micah
Rao, Krishna
Kao, John Y.
Hsieh, Sen-Yung
and
Theis, Kevin R.
2022.
Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
Microbiology Spectrum,
Vol. 10,
Issue. 4,
Ali, Hassam
Patel, Pratik
Pamarthy, Rahul
Fatakhova, Karina
Bolick, Nicole Leigh
and
Satapathy, Sanjaya Kumar
2022.
Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10‐year national cross‐sectional study.
Transplant Infectious Disease,
Vol. 24,
Issue. 6,